TG Therapeutics
TGTX
TGTX
125 hedge funds and large institutions have $548M invested in TG Therapeutics in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more funds holding
Funds holding: 109 → 125 (+16)
0.43% more ownership
Funds ownership: 50.63% → 51.07% (+0.43%)
Holders
125
Holding in Top 10
1
Calls
$17.4M
Puts
$10.4M
Top Buyers
| 1 | +$35.1M | |
| 2 | +$27.5M | |
| 3 | +$8.57M | |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$6.59M |
| 5 |
Millennium Management
New York
|
+$5.54M |
Top Sellers
| 1 | -$28.7M | |
| 2 | -$12.5M | |
| 3 | -$4.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.17M |
| 5 |
JPMorgan Chase & Co
New York
|
-$3.68M |